BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17945893)

  • 1. Classification of cervical cancer cells using FTIR data.
    Njoroge E; Alty SR; Gani MR; Alkatib M
    Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():5338-41. PubMed ID: 17945893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of image analysis and machine learning techniques for automated cervical cancer screening from pap-smear images.
    William W; Ware A; Basaza-Ejiri AH; Obungoloch J
    Comput Methods Programs Biomed; 2018 Oct; 164():15-22. PubMed ID: 30195423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Fourier-transform infrared spectroscopic screening of exfoliated cervical cells with standard Papanicolaou screening.
    Fung Kee Fung M; Senterman M; Eid P; Faught W; Mikhael NZ; Wong PT
    Gynecol Oncol; 1997 Jul; 66(1):10-5. PubMed ID: 9234913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study between Pap smear cytology and FTIR spectroscopy: a new tool for screening for cervical cancer.
    El-Tawil SG; Adnan R; Muhamed ZN; Othman NH
    Pathology; 2008 Oct; 40(6):600-3. PubMed ID: 18752127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pap-smear analysis tool (PAT) for detection of cervical cancer from pap-smear images.
    William W; Ware A; Basaza-Ejiri AH; Obungoloch J
    Biomed Eng Online; 2019 Feb; 18(1):16. PubMed ID: 30755214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A decade has passed...the Pap smear and cervical cancer.
    Linder J
    Am J Clin Pathol; 1997 Nov; 108(5):492-8. PubMed ID: 9353086
    [No Abstract]   [Full Text] [Related]  

  • 7. Papanicolaou smear: can we make a good test better? Technical and interpretive challenges for the practitioner.
    Eltabbakh GH; Eltabbakh GD
    J Womens Health Gend Based Med; 1999 May; 8(4):469-76. PubMed ID: 10839701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep Convolution Neural Network for Malignancy Detection and Classification in Microscopic Uterine Cervix Cell Images.
    P B S; Faruqi F; K S H; Kudva R
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3447-3456. PubMed ID: 31759371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant reduction in the rate of false-negative cervical smears with neural network-based technology (PAPNET Testing System).
    Koss LG; Sherman ME; Cohen MB; Anes AR; Darragh TM; Lemos LB; McClellan BJ; Rosenthal DL; Keyhani-Rofagha S; Schreiber K; Valente PT
    Hum Pathol; 1997 Oct; 28(10):1196-203. PubMed ID: 9343327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nominated texture based cervical cancer classification.
    Mariarputham EJ; Stephen A
    Comput Math Methods Med; 2015; 2015():586928. PubMed ID: 25649913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new approach for the detection of cervical cancer in Thai women.
    Sindhuphak R; Issaravanich S; Udomprasertgul V; Srisookho P; Warakamin S; Sindhuphak S; Boonbundarlchai R; Dusitsin N
    Gynecol Oncol; 2003 Jul; 90(1):10-4. PubMed ID: 12821335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated quantitative fluorescent image analysis of cervical cytology.
    Smith JJ; Cowan L; Hemstreet G; Smith ML; Pippitt CH; Doggett R; McGill L
    Gynecol Oncol; 1987 Nov; 28(3):241-54. PubMed ID: 3678975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fourier transform infrared microspectroscopy as a quantitative diagnostic tool for assignment of premalignancy grading in cervical neoplasia.
    Mark S; Sahu RK; Kantarovich K; Podshyvalov A; Guterman H; Goldstein J; Jagannathan R; Argov S; Mordechai S
    J Biomed Opt; 2004; 9(3):558-67. PubMed ID: 15189094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of a self-administered tampon ThinPrep test with conventional pap smears for cervical cytology.
    Budge M; Halford J; Haran M; Mein J; Wright G
    Aust N Z J Obstet Gynaecol; 2005 Jun; 45(3):215-9. PubMed ID: 15904447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current status of the Papanicolaou smear.
    Shingleton HM; Patrick RL; Johnston WW; Smith RA
    CA Cancer J Clin; 1995; 45(5):305-20. PubMed ID: 7656133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New tests for cervical cancer screening.
    Nuovo J; Melnikow J; Howell LP
    Am Fam Physician; 2001 Sep; 64(5):780-6. PubMed ID: 11563569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detailed account of confounding factors in interpretation of FTIR spectra of exfoliated cervical cells.
    Wong PT; Senterman MK; Jackli P; Wong RK; Salib S; Campbell CE; Feigel R; Faught W; Fung Kee Fung M
    Biopolymers; 2002; 67(6):376-86. PubMed ID: 12209445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pap smear refined.
    Oncology (Williston Park); 1997 Aug; 11(8):1125. PubMed ID: 9268975
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening for cervical cancer using automated analysis of PAP-smears.
    Bengtsson E; Malm P
    Comput Math Methods Med; 2014; 2014():842037. PubMed ID: 24772188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on the Papanicolaou smear: new issues for the 1990s.
    Ollayos CW
    Mil Med; 1997 Aug; 162(8):521-3. PubMed ID: 9271901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.